Trial NCT04956302

View at ClinicalTrials.gov 
Org. Study IDs: OSU-21005
Secondary IDs: NCI-2021-04261

Last trial update was posted on 2022-12-08

MeSH Interventions

Antibodies, Monoclonal BB 1101 Bortezomib Daratumumab Dexamethasone Dexamethasone acetate Ichthammol Panobinostat

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Stopping Reasons

PI Decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID